Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -2.27%1.62B | -3.50%1.59B | -1.50%1.59B | 1.44%6.54B | 2.06%1.62B | 6.81%1.66B | 0.65%1.65B | -3.35%1.62B | 4.63%6.45B | -3.06%1.58B |
| Cost of revenue | 1.71%1.08B | -2.86%1.02B | 0.12%1.02B | 2.46%4.26B | 5.31%1.13B | 9.31%1.06B | 6.64%1.05B | -9.78%1.02B | 9.07%4.16B | -7.60%1.08B |
| Gross profit | -9.34%541.21M | -4.63%569.24M | -4.25%575.69M | -0.42%2.28B | -4.85%482.25M | 2.66%596.99M | -8.40%596.89M | 9.90%601.21M | -2.58%2.29B | 8.21%506.81M |
| Operating expense | -20.37%-47.08M | -178.83%-3.24M | -105.86%-457K | -292.27%-25.61M | 108.07%1.6M | -768.58%-39.11M | -88.42%4.11M | 193.93%7.8M | -51.74%13.32M | 77.52%-19.77M |
| Selling and administrative expenses | -20.03%30.89M | 87.68%62.05M | -18.99%30.11M | 11.30%145.95M | -5.11%37.09M | 37.44%38.62M | 10.21%33.06M | 9.53%37.17M | 15.49%131.12M | 27.10%39.09M |
| -General and administrative expense | -20.03%30.89M | 87.68%62.05M | -18.99%30.11M | 11.30%145.95M | -5.11%37.09M | 37.44%38.62M | 10.21%33.06M | 9.53%37.17M | 15.49%131.12M | 27.10%39.09M |
| Other operating expenses | -44.82%5.54M | 278.73%9.19M | -98.09%264K | -94.64%2.96M | 1,291.68%41.65M | -24.30%10.05M | -94.48%2.43M | 618.98%13.83M | -28.17%55.18M | 105.83%2.99M |
| Total other operating income | -4.87%83.51M | 137.40%74.48M | -28.63%30.84M | 0.88%174.51M | 24.73%77.15M | 147.12%87.78M | -18.27%31.37M | -2.16%43.2M | 6.29%172.98M | -8.14%61.85M |
| Operating profit | -7.52%588.29M | -3.42%572.48M | -2.91%576.14M | 1.29%2.3B | -8.72%480.66M | 10.50%636.1M | -3.78%592.78M | 6.85%593.42M | -2.00%2.27B | -5.35%526.59M |
| Net non-operating interest income (expenses) | 7.02%-20.86M | 13.79%-19.94M | 11.99%-20.23M | 29.08%-89.89M | 8.85%-21.35M | 5.04%-22.43M | 37.33%-23.12M | 46.31%-22.99M | 28.96%-126.76M | 50.61%-23.43M |
| Non-operating interest expense | -7.02%20.86M | -13.79%19.94M | -11.99%20.23M | -29.08%89.89M | -8.85%21.35M | -5.04%22.43M | -37.33%23.12M | -46.31%22.99M | -28.96%126.76M | -50.61%23.43M |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | -33.30%40.72M | -5.26%42.72M | 108.01%55.99M | -38.39%147.29M | -86.48%14.24M | 43.89%61.05M | -3.99%45.09M | -39.35%26.92M | 87.20%239.08M | 467.37%105.32M |
| Special income (charges) | ||||||||||
| Other non-operating income (expenses) | ||||||||||
| Income before tax | -9.87%608.15M | -3.17%595.27M | 2.44%611.9M | -1.08%2.36B | -22.18%473.54M | 13.50%674.72M | -1.82%614.74M | 7.26%597.35M | 5.14%2.39B | 15.36%608.48M |
| Income tax | 5.20%140.46M | -6.53%115.71M | -4.17%119.84M | -9.95%436.7M | -61.97%54.33M | 29.22%133.52M | -4.88%123.8M | 15.10%125.05M | -5.07%484.98M | 118.58%142.86M |
| Net income | -13.58%467.69M | -2.32%479.55M | 4.18%492.06M | 1.19%1.92B | -9.97%419.21M | 10.19%541.2M | -1.01%490.95M | 5.35%472.29M | 8.11%1.9B | 0.76%465.61M |
| Net income continuous operations | -13.58%467.69M | -2.32%479.55M | 4.18%492.06M | 1.19%1.92B | -9.97%419.21M | 10.19%541.2M | -1.01%490.95M | 5.35%472.29M | 8.11%1.9B | 0.76%465.61M |
| Noncontrolling interests | -50.63%23.47M | 33.77%29.37M | 48.64%23.26M | 7.21%87.31M | -90.93%2.18M | 109.36%47.53M | 107.14%21.95M | -35.12%15.65M | -27.94%81.44M | -51.52%24.02M |
| Net income attributable to the company | -10.02%444.23M | -4.01%450.19M | 2.66%468.8M | 0.92%1.84B | -5.56%417.03M | 5.38%493.67M | -3.37%468.99M | 7.65%456.65M | 10.58%1.82B | 7.04%441.59M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -10.02%444.23M | -4.01%450.19M | 2.66%468.8M | 0.92%1.84B | -5.56%417.03M | 5.38%493.67M | -3.37%468.99M | 7.65%456.65M | 10.58%1.82B | 7.04%441.59M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -10.02%0.2245 | -4.01%0.2275 | 2.64%0.2369 | 0.87%0.928 | -5.56%0.2108 | 5.41%0.2495 | -3.38%0.237 | 7.65%0.2308 | 10.58%0.92 | 6.85%0.2232 |
| Diluted earnings per share | -10.02%0.2245 | -4.01%0.2275 | 2.64%0.2369 | 0.87%0.928 | -5.56%0.2108 | 5.41%0.2495 | -3.38%0.237 | 7.65%0.2308 | 10.58%0.92 | 6.85%0.2232 |
| Dividend per share | 0.00%0.16 | 0.00%0.16 | 0.00%0.22 | 0.00%0.72 | 0.00%0.18 | 0.00%0.16 | 0.00%0.16 | 0.00%0.22 | 0.00%0.72 | 0.00%0.18 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.